Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc., 38217-38218 [2016-13914]
Download as PDF
<![CDATA[
38217
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
We will summarize written responses
to this notice and address them in our
submission for OMB approval. As a
result of your comments, we will make
any necessary adjustments to the burden
in our submission to OMB.
Public Comment Procedures: Before
including your address, phone number,
email address, or other personal
identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
BSEE Information Collection
Clearance Officer: Nicole Mason (703)
787–1607.
Dated: June 3, 2016.
Robert W. Middleton,
Deputy Chief, Office of Offshore Regulatory
Programs.
[FR Doc. 2016–13862 Filed 6–10–16; 8:45 am]
BILLING CODE 4310–VH–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–16–019]
Sunshine Act Meeting
United
States International Trade Commission.
TIME AND DATE: June 16, 2016 at 11:00
a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: None.
2. Minutes.
3. Ratification List.
4. Vote in Inv. No. 731–TA–1071
(Second Review) (Alloy Magnesium
from China). The Commission is
currently scheduled to complete and file
its determination and views of the
Commission on June 30, 2016.
AGENCY HOLDING THE MEETING:
5. Outstanding action jackets: None.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
DEPARTMENT OF JUSTICE
By order of the Commission.
Issued: June 8, 2016.
William R. Bishop,
Supervisory Hearings and Information
Officer.
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc.
[FR Doc. 2016–14045 Filed 6–9–16; 4:15 pm]
Drug Enforcement Administration
[Docket No. DEA–392]
ACTION:
Notice of application.
[USITC SE–16–020]
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 12, 2016.
Sunshine Act Meeting
ADDRESSES:
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
United
States International Trade Commission.
TIME AND DATE: June 22, 2016 at 11:00
a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: None.
2. Minutes.
3. Ratification List.
4. Vote in Inv. Nos. 701–TA–541 and
731–TA–1284 and 1286 (Final) (ColdRolled Steel Flat Products from China
and Japan). The Commission is
currently scheduled to complete and file
its determinations and views of the
Commission on July 5, 2016.
5. Outstanding action jackets: None.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
By order of the Commission.
Issued: June 8, 2016.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2016–14044 Filed 6–9–16; 4:15 pm]
BILLING CODE 7020–02–P
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
February 1, 2016, Sigma Aldrich
Research Biochemicals, Inc., 1–3
Strathmore Road, Natick, Massachusetts
01760–2447 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
SUPPLEMENTARY INFORMATION:
srobinson on DSK5SPTVN1PROD with NOTICES
Controlled substance
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) (1248) ....................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
VerDate Sep<11>2014
20:48 Jun 10, 2016
Jkt 238001
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
E:\FR\FM\13JNN1.SGM
13JNN1
I
I
I
I
I
I
I
I
I
I
I
I
38218
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
Controlled substance
Schedule
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine (7439) ..............................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
N-Benzylpiperazine (7493) ..........................................................................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) (7535) .......................................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) .......................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Norlevorphanol (9634) .................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
1-Phenylcyclohexylamine (7460) .................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Metazocine (9240) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Remifentanil (9739) .....................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
Carfentanil (9743) ........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
The company plans to manufacture
reference standards.
Comments are encouraged and
will be accepted for 60 days until
August 12, 2016.
DATES:
Dated: June 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Clifton A. Coward, Jr., Office of
Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2016–13914 Filed 6–10–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0023]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection—Import/Export
Declaration for List I and List II
Chemicals, DEA Forms 486, 486A
Drug Enforcement
Administration, Department of Justice
ACTION: 60-Day notice.
srobinson on DSK5SPTVN1PROD with NOTICES
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
SUMMARY:
VerDate Sep<11>2014
20:48 Jun 10, 2016
Jkt 238001
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Import/Export Declaration for List I and
List II Chemicals.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Forms: 486, 486A. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Pages 38217-38218]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13914]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Sigma
Aldrich Research Biochemicals, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before August 12, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
February 1, 2016, Sigma Aldrich Research Biochemicals, Inc., 1-3
Strathmore Road, Natick, Massachusetts 01760-2447 applied to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Cathinone (1235)................................. I
Methcathinone (1237)............................. I
Mephedrone (4-Methyl-N-methylcathinone) (1248)... I
Aminorex (1585).................................. I
Alpha-ethyltryptamine (7249)..................... I
Lysergic acid diethylamide (7315)................ I
Tetrahydrocannabinols (7370)..................... I
4-Bromo-2,5-dimethoxyamphetamine (7391).......... I
4-Bromo-2,5-dimethoxyphenethylamine (7392)....... I
4-Methyl-2,5-dimethoxyamphetamine (7395)......... I
2,5-Dimethoxyamphetamine (7396).................. I
3,4-Methylenedioxyamphetamine (7400)............. I
[[Page 38218]]
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)... I
3,4-Methylenedioxy-N-ethylamphetamine (7404)..... I
3,4-Methylenedioxymethamphetamine (7405)......... I
Dimethyltryptamine (7435)........................ I
Psilocybin (7437)................................ I
5-Methoxy-N,N-diisopropyltryptamine (7439)....... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)..... I
N-Benzylpiperazine (7493)........................ I
MDPV (3,4-Methylenedioxypyrovalerone) (7535)..... I
Methylone (3,4-Methylenedioxy-N-methylcathinone) I
(7540).
Heroin (9200).................................... I
Normorphine (9313)............................... I
Norlevorphanol (9634)............................ I
Amphetamine (1100)............................... II
Methamphetamine (1105)........................... II
Nabilone (7379).................................. II
1-Phenylcyclohexylamine (7460)................... II
Phencyclidine (7471)............................. II
Cocaine (9041)................................... II
Codeine (9050)................................... II
Ecgonine (9180).................................. II
Levomethorphan (9210)............................ II
Levorphanol (9220)............................... II
Meperidine (9230)................................ II
Metazocine (9240)................................ II
Methadone (9250)................................. II
Morphine (9300).................................. II
Thebaine (9333).................................. II
Levo-alphacetylmethadol (9648)................... II
Remifentanil (9739).............................. II
Sufentanil (9740)................................ II
Carfentanil (9743)............................... II
Fentanyl (9801).................................. II
------------------------------------------------------------------------
The company plans to manufacture reference standards.
Dated: June 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-13914 Filed 6-10-16; 8:45 am]
BILLING CODE 4410-09-P
